1. Hemophilia A and B
A) Factor VIII and Factor IX variant analysis
B) Carrier diagnosis
C) Prenatal testing
2. von Willebrand Disease
A) Analysis for Type 2N VWD
B) Confirmation of type 1C, 2A, 2B or 2M VWD
C) Variant analysis and prenatal testing for type 3 VWD
3. Rare Bleeding Disorders (including)
A) Factor V
B) Factor VII
C) Factor X
D) Factor XI
E) Factor XIII
Genetic testing for Hemophilia A, B, and von Willebrand disease is authorized by our current laboratory license (Ministry of Health and Long Term Care), and within the scope of our accreditation (Accreditation Canada Diagnostics). Rare bleeding disorder testing is performed on a research basis.
REASONS FOR REFERRAL
For quantitative disorders (hemophilia A, hemophilia B, type 1C and type 3 VWD, and rare bleeding disoders) a clotting factor level is required.
For qualitative disorders (type 2A, 2B, 2M VWD), VWF:Ag and VWF activity (VWF:RCo, VWF:GPIBM, etc.) must be provided. For some cases, VWF multimer analysis, RIPA and/or a desmopressin study may be required.
We do not accept referrals for undiagnosed bleeding disorders.
DNA or whole blood is sent to the NIBDGL at Queen’s University. Genetic analysis is performed by Sanger sequencing of the coding region of the gene of interest.
For severe hemophilia A, F8 intron 22 inversion analysis is performed by inverse shifting PCR. F8 intron 1 inversion testing is also performed.
TURN AROUND TIMES AND REPORTING
The average time for test reporting for affected patients is approximately 2-3 months from the time of sample submission.
If the family-specific variant is known, urgent reporting can be completed within several weeks. STAT testing for rare bleeding disorders is not available.
Carrier testing for females with an unknown family history may take 3-6 months. in these cases provisional reports may be issued prior to final confirmation.
For some patients, variants are not immediately identified and in these cases the search for the causative genetic change may take several months.
Reports will only be issued to healthcare providers listed on the requisition forms.